Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
Small‐cell lung cancer (SCLC) can be subgrouped into common ‘pure’ and rare ‘combined’ SCLC (c‐SCLC). c‐SCLC features a mixed tumor histology of both SCLC and non–small‐cell lung cancer (NSCLC). We performed targeted exome sequencing on 90 patients with SCLC, including two with c‐SCLC, and discovere...
Main Authors: | Tian He, Gary Wildey, Karen McColl, Alyssa Savadelis, Kyle Spainhower, Cassidy McColl, Adam Kresak, Aik Choon Tan, Michael Yang, Ata Abbas, Afshin Dowlati |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12829 |
Similar Items
-
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
by: Justin Loke, et al.
Published: (2017-05-01) -
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
by: Emiel van der Kouwe, et al.
Published: (2019-01-01) -
Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment
by: LL Girshova, et al.
Published: (2016-10-01) -
Interplay between transcription factors and the epigenome: Insight from the role of RUNX1 in leukemia.
by: Kate Helen Brettingham-Moore, et al.
Published: (2015-09-01) -
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with <i>RUNX1</i>-<i>RUNX1T1</i> Fusion
by: Jae Won Yun, et al.
Published: (2019-04-01)